FDA Clears Lowering Age Requirement of Cochlear Device
Cochlear's Osia System utilizes digital piezoelectric stimulation to transmit sound vibrations directly to the inner ear.
Cochlear's Osia System utilizes digital piezoelectric stimulation to transmit sound vibrations directly to the inner ear.
A global survey put out by York University shows how many adults are satisfied with their cochlear implants, and that additional support is needed.
The Hearing Review is joined by audiologist Duncan Floyd to talk about why the Optimized Method of masking can be so helpful in audiometry.
University Hospitals Cleveland Medical Center and UH Rainbow Babies and Children’s Hospital are participating in a Cochlear Americas’-sponsored clinical trial for an implantable hearing device in children 5 to 11 years of age who have been born with hearing loss that may be caused by craniofacial abnormalities.
New Jersey State-regulated health insurers may soon be required to cover hearing aids and cochlear implants for individuals under 21 years of age, thanks to a bill sponsored by Senator Vince Polistina that was approved by the Senate Budget and Appropriations Committee.
Envoy Medical Corporation, a hearing health company focused on providing innovative technologies across the hearing loss spectrum, announced an independent study that was published online in 'The Journal of Laryngology & Otology.' The study found that the fully implanted Esteem osseointegrated active middle ear implant (AMEI) showed “statistically significant improvements in post-operative hearing results,” according to Envoy.